These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33587283)

  • 21. Efficacy of topical corticosteroids on irritant skin reactions.
    Ramsing DW; Agner T
    Contact Dermatitis; 1995 May; 32(5):293-7. PubMed ID: 7634784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
    Vena GA; Cassano N; Coco V; De Simone C
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):447-50. PubMed ID: 23672527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact sensitization in venous eczema: preliminary results of patch testing with Indian standard series and topical medicaments.
    Jindal R; Sharma NL; Mahajan VK; Tegta GR
    Indian J Dermatol Venereol Leprol; 2009; 75(2):136-41. PubMed ID: 19293499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allergy to largactil; eczematous contact reactions].
    ZAVARINI G
    Minerva Dermatol; 1955 Jul; 30(7):213-4. PubMed ID: 13279698
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergic contact dermatitis caused by transdermal hyoscine.
    Gordon CR; Shupak A; Doweck I; Spitzer O
    BMJ; 1989 May; 298(6682):1220-1. PubMed ID: 2526675
    [No Abstract]   [Full Text] [Related]  

  • 27. Granulomatous Cutaneous Drug Eruptions: A Systematic Review.
    Shah N; Shah M; Drucker AM; Shear NH; Ziv M; Dodiuk-Gad RP
    Am J Clin Dermatol; 2021 Jan; 22(1):39-53. PubMed ID: 33108647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatological reactions to ophthalmic preparations: more than meets the eye.
    Byrom L; Zappala T; Muir J
    Australas J Dermatol; 2014 May; 55(2):95-8. PubMed ID: 24528088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eczematous dermatitis: a practical review.
    Zug KA; McKay M
    Am Fam Physician; 1996 Sep; 54(4):1243-50, 1253-4. PubMed ID: 8816570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
    Sibaud V
    Am J Clin Dermatol; 2018 Jun; 19(3):345-361. PubMed ID: 29256113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eczema in elderly people.
    Tétart F; Joly P
    Eur J Dermatol; 2020 Dec; 30(6):663-667. PubMed ID: 33258454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative studies on various test methods in allergic contact sensitization against neomycin-sulfate].
    Bielický T; Novák M
    Z Haut Geschlechtskr; 1971 Nov; 46(21):771-7. PubMed ID: 4256382
    [No Abstract]   [Full Text] [Related]  

  • 33. [Allergic contact eczema in general practice].
    Schröpl F
    Ther Umsch; 1974 May; 31(5):307-12. PubMed ID: 4282888
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differential diagnosis of allergic eczema].
    Steigleder GK
    Hautarzt; 1975 Feb; 26(2):62-4. PubMed ID: 123884
    [No Abstract]   [Full Text] [Related]  

  • 35. Dry skin and skin barrier in early infancy.
    Rehbinder EM; Winger AJ; Landrø L; Asarnoj A; Berents TL; Carlsen KH; Hedlin G; Jonassen CM; Nordlund B; Sandvik L; Skjerven HO; Söderhäll C; Vettukattil R; Carlsen KCL;
    Br J Dermatol; 2019 Jul; 181(1):218-219. PubMed ID: 30637724
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous immune-related adverse events to checkpoint inhibitors.
    Malviya N; Tattersall IW; Leventhal J; Alloo A
    Clin Dermatol; 2020; 38(6):660-678. PubMed ID: 33341200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event.
    Sanz-Navarro J; Feal C; Dauden E
    Actas Dermosifiliogr; 2017 Sep; 108(7):643-649. PubMed ID: 28385424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s5-s10. PubMed ID: 23377405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contact eczema and drug ionization].
    Laporte M
    Acta Belg Med Phys; 1984; 7(3):97-9. PubMed ID: 6240181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.